Gregg A. Mosley, President of Biotest Laboratories of Minneapolis, MN, to Address Biological Counter-Terrorism Seminar on “Methods of Destruction for the Root Causes of Contamination by Dangerous Pathogens”

MINNEAPOLIS, MN and NEW YORK, NY--(Marketwire - November 17, 2009) - Gregg Mosley, President of Biotest Laboratories of Minneapolis, MN (www.biotestlabs.com), a world-renowned expert in sterilization of medical products, will address the Biological Counter-Terrorism Seminar hosted by BioDefense Corporation, November 17, 2009 at the Waldorf Astoria Hotel, New York, NY.

According to host John Meyer, President of BioDefense Corporation (NYPD-Retired), “Bioterrorism is an ever-present threat to any entity, public or private. Potential perpetrators such as disgruntled employees and customers, business competitors, activists, extortionists, terrorists, and any others with ill intent will be described and discussed. Special focus will be on understanding how a bio-pathogen attack occurs and what procedures can be employed to mitigate infection and contamination.”

Mr. Mosley will discuss potential types of agents used for bioterrorism and sterilization methods for destruction. Biotest Laboratories has created a system for “Managing Microbes” based on principles of Evariology that allows trending and tracking of problematic organisms for medical manufacturers. It is a risk management process involving proactive bioburden monitoring devices and production environment, allowing identification and prevention of the root causes of contamination.

“We envision application of these same principles to bioterrorism in order that they can be used to identify various attack organisms or toxins and potentially predict what biological may be used by terrorists and where such an attack could occur,” explained Mr. Mosley.

Working in conjunction with BioDefense Corp. of Massachusetts (www.biod.com) Biotest has developed a challenge test pack called MAIL SAFE CHECK™ that can test the effects of numerous types of sterilization processes at the same time. The test pack contains proprietary biological and chemical indicators more resistant than the typical pathogens used for bioterrorism such as anthrax. Successful inactivation of the challenges in the test pack assure inactivation of potential attack organisms.

About Biotest Laboratories, Inc.

Gregg A. Mosley organized Biotest Laboratories, Inc. in 1988 as a test laboratory for manufacturers of medical products. To meet growing customer requests, Biotest Laboratories has developed areas of Contract Manufacturing, Packaging/Assembly, Contract Steam Sterilization, Cleanroom/Cleanbench Testing and Certification, Validation Services, Microbial Management (Evariology), and Training and Consulting Services. The company presently employs approximately 80 people and is headquartered at 8990 Springbrook Drive NW, Suite 100, Minneapolis, MN 55433. Telephone 763-785-2414 or visit www.biotestlabs.com.

About BioDefense Corporation

Over the past eight years, BioDefense Corporation has developed multiple Mail Defender prototypes, and is now bringing to market its first commercial production unit. BioDefense has secured a patent for the technology containing over 30 claims, and has completed independent testing from multiple laboratories under government supervision confirming the efficacy of the technology. Current customers for the Mail Defender include the United Nations, U.S. Military, and other high-profile government and financial institutions. Headquarters are at 12 Channel Street, Boston, MA 02210. Tel: 617-778-1800.